Chief Commercial Officer

Toxiproof

AI is building next-generation AI infrastructure for predictive toxicology and pharmacogenomic intelligence. We enable pharmaceutical companies, biotech SMEs, and CROs to make safer, faster, and more data-driven decisions in drug development.

Our platform integrates advanced AI with clinical, genomic, and molecular data to reduce late-stage failure risk and improve precision in therapeutic development.

We are entering our commercial inflection point and are seeking a strategic, deal-driven commercial leader to shape and execute our global business development strategy.

We are looking for a Chief Commercial Officer (CCO) with deep domain expertise in:

• Pharmacogenomics / Precision Medicine
• Pharmaceutical R&D workflows
• CRO ecosystems
• Strategic deal‑making in early-stage companies

This is not a growth‑scaling role yet.

This is a zero-to-one commercial architect role focused on:

• Strategic partnerships
• Design partnerships
• Platform validation contracts
• Long‑cycle enterprise negotiations

You will define our commercial foundation.

• Strategic Commercial Leadership
• Develop and own Toxiproof
  
  AI’s global commercial strategy
• Build early lighthouse accounts and anchor partnerships
• Lead complex, multi‑stakeholder negotiations with:
  • Large Pharmaceutical companies
  • Precision medicine biotechs
  • Clinical CRO organizations
• Structure strategic partnerships (co‑development, data‑sharing, licensing)
• Establish framework agreements and multi‑year SaaS contracts

• Build relationships with R&D leadership (CSO, VP Translational Medicine, Head of Toxicology), Clinical development leaders, Pharmacogenomics and biomarker teams
• Identify integration opportunities within existing pharma workflows
• Represent Toxiproof
  
  AI at key industry conferences and partnering events
• Define early revenue model and forecasting approach
• Support fundraising with commercial validation
• Contribute to investor narratives around pipeline and partnerships
• Build the initial commercial team when appropriate

• 10+ years in life sciences / healthcare commercial leadership
• Proven track record of enterprise deal‑making in:
  Big Pharma, Biotech SMEs, CRO environments
• Experience commercializing: AI platforms, Genomics solutions, SaaS products in drug development
• Prior role as CCO, CBDO, VP BD, or equivalent in early‑stage or scale‑up biotech/healthtech

• Background in pharmacogenomics, toxicology, or translational medicine
• Experience structuring data partnerships
• Understanding of regulatory environments impacting AI in healthcare

• Strategic thinker with execution bias
• Deeply relationship‑driven
• Commercially rigorous but scientifically fluent
• High ownership mentality

• 3–5 strategic lighthouse partnerships signed
• At least 2 enterprise pharma pilot programs launched
• Clear, validated pricing model
• Commercial pipeline aligned with fundraising milestones

• Opportunity to define commercial strategy from first principles
• Direct impact on safer drug development and patient outcomes
• Foundational executive role with equity participation
• Work at the intersection of AI, genomics, and pharmaceutical innovation
• Remote‑based role with flexible working arrangements